Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients
{{output}}
Background Therapeutic drug monitoring of mycophenolic acid (MPA) is required to optimize the immunosuppressive effect and minimize toxicity. We validated a new particle-enhanced turbidimetric inhibition immunoassay (PETINIA) for the determination of MPA level... ...
